Exhibitor
Volition
| Country: | Belgium |
| Booth number: | #17 |
| Website: | https://volition.com/ |
Company profile
Nu.Q Discover offers access to a proprietary biomarker platform that quantifies cf-nucleosomes across bio-fluids, for use in preclinical and clinical drug developments. It targets biomarkers associated with innate immune activation (NETs) and epigenetic inhibitors (HDACi, EEDi, etc.), aiding in disease and tumor burden correlation. Useful for dose optimisation, treatment response and disease monitoring, Nu.Q assays also encompass a proteomics approach and toxicity monitoring.
